Skip to main content

Table 1 Sociodemographic, anthropometric and clinical characteristics of participants included in the study

From: Saliva as a non-invasive specimen for COPD assessment

Characteristics

COPD (n = 70)

HEALTHY (n = 58)

p-value

Age (years), mean ± SD

67.9 ± 8.7

67.0 ± 8.2

0.7

Male sex, n (%)

60 (86%)

42 (84%)

0.8

BMI (kg/m2), mean ± SD

25.5 ± 3.5

27.6 ± 3.8

0.001

Pack-years, mean ± SD

42.2 ± 45.3

8 ± 21.0

 < 0.0001

CCI, mean ± SD

3.7 ± 1.3

2.0 ± 1.0

 < 0.0001

Medication for COPD, n (%)

70 (100%)

0 (0%)

 

Smoking status, n (%)

   

 Current smoker

7 (10%)

2 (4%)

 < 0.0001

 Former smoker

49 (70%)

10 (20%)

 Never smoker

14 (20%)

38 (76%)

GOLD Grade, n (%)

   

 1

7 (10%)

n.a

 

 2

25 (36%)

n.a

 3

26 (37%)

n.a

 4

12 (17%)

n.a

GOLD Group, n (%)

   

 A

12 (17%)

n.a

 

 B

32 (46%)

n.a

 C

5 (7%)

n.a

 D

21 (30%)

n.a

Long-term oxygen dependence, n (%)

11 (16%)

0 (0)

 

SpO2, mean ± SD (%)

94.4 ± 1.9

96.7 ± 1.7

 < 0.0001

FEV1 (L)

1.3 ± 0.4

2.8 ± 0.6

 < 0.0001

FEV1pp, mean ± SD

48.0 ± 16.4

103.0 ± 16.7

 < 0.0001

FVC (L)

2.7 ± 0.6

3.4 ± 0.7

 < 0.0001

Ratio FEV1FVC

48.7 ± 12.1

83.8 ± 8.7

 < 0.0001

Number of exacerbations in the year before enrolment, n (%)

   

 0–1

49 (70%)

n.a

 

 ≥ 2 or 1 with hospital admission

21 (30%)

n.a

Hospital admissions due to COPD, in the year before enrolment, n (%)

   

 0

60 (86%)

n.a

 

 1

10 (14%)

n.a

  1. Comparisons between people with COPD and Healthy controls were conducted with unpaired t-test with Welch’s correction, Mann–Whitney U-test and Fisher’s exact test. n (%): number of individuals in each group plus the corresponding percentage. mean±SD: mean±standard deviation. CCI: Charlson Comorbidity Index; BMI: Body Mass Index; GOLD Grade: 3—Severe; 4—Very Severe; GOLD Group: A—Less symptoms and low risk of exacerbations; B—More symptoms and low risk of exacerbations; C– Less symptoms and high risk of exacerbations; D—More symptoms and high risk of exacerbations; FEV1pp: forced expiratory volume in 1 second percentage of predicted; SpO2: peripheral capillary oxygen saturation. Comparisons between patients with COPD and Healthy controls were conducted with unpaired t-test with Welch’s correction, Mann-Whitney U-test and Fisher’s exact test